Dividends & Buybacks ·
BioRestorative Therapies implements one-for-twenty reverse stock split to regain Nasdaq compliance
BRTXBioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. announced a one-for-twenty (1-for-20) reverse stock split of its common stock to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The transaction was approved by the Board on August 27, 2026, and filed with the Nevada Secretary of State on September 2, 2026. The split becomes effective at 4:30 p.m. ET on September 7, 2026, with adjusted trading beginning September 8, 2026. Outstanding shares will decrease from approximately 27.6 million to roughly 1.38 million, and authorized common stock will be reduced proportionally from 1.5 billion to 75 million shares. Fractional shares are rounded up to the nearest whole share. BioRestorative Therapies operates in the biotechnology industry, developing regenerative medicine products using cell and tissue protocols.